Tag: pharmaceuticals
Is the Purdue Settlement a Win for Harm Reduction?
The battle to hold corporations accountable for their involvement in fueling chaotic opioid use ...
Pain Patients Like Me Are Rising Up Against Discrimination and Suffering
If it were up to me, it’s unlikely I would be sitting down to ...
Gilead Relinquishes Its PrEP Patent—But Did It Mislead Investors?
On May 8, pharmaceutical company Gilead quietly announced that it will relinquish its exclusive ...
Bernie Sanders Backs #BreakThePatent Fight for Universal PrEP Access
The fight for universal access to PrEP medication for HIV prevention was picked up ...
New “Generic” Naloxone: Expect More Big-Pharma Sleight of Hand
It’s been less than two weeks since the US Department of Justice joined a ...
DEA’s “Innovative” Strategy in New Orleans Encourages Ever-Harsher Prosecutions
On April 16, the Drug Enforcement Administration (DEA) launched its latest punishment-driven, treatment-inflected response ...
Indivior Case: Don’t Throw Out the Buprenorphine With the Bathwater
In the lucrative but hit-and-miss opioid use disorder treatment field, buprenorphine is one medication ...
US Buprenorphine Prices: A Complete List
To accompany Alison Knopf’s April 16 article about buprenorphine in light of federal charges ...
“Nation’s Most Comprehensive Lawsuit”—Now NY Takes On Purdue and the Sacklers
Museums around the world, from New York City’s Guggenheim to London’s Tate Modern, have ...
Rethinking Ketamine in Light of a Newly Approved Depression Treatment
On March 5, the US Food and Drug Administration (FDA) approved the prescription treatment ...
